Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Scientific Reports|June 14, 2024
Liraglutide exhibits potential anti-tumor effects on the progression of intrahepatic cholangiocarcinoma, in vitro and in vivoRonnakrit Trakoonsenathong, Waritta Kunprom, Chaiwat Aphivatanasiri, et al.
Nutrition and Cancer|August 31, 2025
Preoperative Glucose-Lymphocyte Ratio: A New Potential Prognostic Marker for Patients with CholangiocarcinomaKrittapoj Sutanthavibul, Ronnakrit Trakoonsenathong, Luxzup Wattanasukchai, et al.
World Journal of Gastroenterology|August 14, 2023
γ-aminobutyric acid B2 receptor: A potential therapeutic target for cholangiocarcinoma in patients with diabetes mellitusCharupong Saengboonmee, Supannika Sorin, Sakkarn Sangkhamanon, et al.
Translational Gastroenterology and Hepatology|August 2, 2024
Involvement of interleukin-1β in high glucose-activated proliferation of cholangiocarcinomaKullanat Khawkhiaw, Surang Chomphoo, Waritta Kunprom, et al.
Life Sciences|October 10, 2020
NF-κB and STAT3 co-operation enhances high glucose induced aggressiveness of cholangiocarcinoma cellsCharupong Saengboonmee, Chatchai Phoomak, Suangson Supabphol, et al.
Biochimica Et Biophysica Acta. General Subjects|October 9, 2023
Induction of apoptotic cell death of cholangiocarcinoma cells by tiliacorinine from Tiliacora triandra: A mechanistic insightMarutpong Detarya, Panupong Mahalapbutr, Orawan Waenphimai, et al.
SAGE Open Medicine|August 6, 2026
HMGA1 is associated with unfavorable outcome and accelerates the aggressiveness of cholangiocarcinomaRatthaphong Phumphu, Saowaluk Saisomboon, Piya Prajumwong, et al.
Molecular Metabolism|August 22, 2022
Phosphomimetic Dicer S1016E triggers a switch to glutamine metabolism in gemcitabine-resistant pancreatic cancerJi Min Park, Jei-Ming Peng, Yu-Shiuan Shen, et al.
Cancers|October 26, 2024
Insights into Metabolic Reprogramming in Tumor Evolution and TherapyChing-Feng Chiu, Jonathan Jaime G Guerrero, Ric Ryan H Regalado, et al.
Cancers|February 20, 2025
Correction: Chiu et al. Insights into Metabolic Reprogramming in Tumor Evolution and Therapy. Cancers 2024, 16, 3513Ching-Feng Chiu, Jonathan Jaime G Guerrero, Ric Ryan H Regalado, et al.
Pageof 6